Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,507.92 6.27 0.04%
S&P 500 1,878.12 2.73 0.15%
NASDAQ 4,149.32 22.35 0.54%
Ticker Volume Price Price Delta
STOXX 50 3,189.81 13.84 0.44%
FTSE 100 6,703.00 28.26 0.42%
DAX 9,548.68 4.49 0.05%
Ticker Volume Price Price Delta
NIKKEI 14,404.99 -141.28 -0.97%
TOPIX 1,164.90 -8.91 -0.76%
HANG SENG 22,562.80 53.16 0.24%

Medivation Announces Participation at Upcoming Investor Conferences


Medivation Announces Participation at Upcoming Investor Conferences

SAN FRANCISCO, CA -- (Marketwired) -- 05/06/13 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conferences:


 
--  David Hung, M.D., president and chief executive officer, will present
    at the UBS Global Healthcare Conference on May 20 at 1pm ET at the
    Grand Hyatt in New York, NY.
--  David Hung, M.D., president and chief executive officer, will present
    at the 38th Annual dbAccess Health Care Conference on May 29 at 4:50pm
    ET at the Westin Boston Waterfront in Boston, MA.
--  Patrick Machado, chief business and financial officer, will present at
    the Jefferies 2013 Global Healthcare Conference on June 3 at 11am ET
    at the Grand Hyatt in New York, NY.
--  David Hung, M.D., president and chief executive officer, will present
    at the Goldman Sachs 34th Annual Global Healthcare Conference, on June
    11 at 4pm PT at the Terranea Resort in Rancho Palos Verdes, CA.

Individuals may access the live audio webcast by visiting: http://investors.medivation.com/events.cfm. A replay of the webcast will be available on the Company's website for 30 days following the live event.

About Medivation Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at www.medivation.com.

Contacts: Patrick Machado Chief Business & Financial Officer (415) 829-4101

Anne Bowdidge Sr. Director, Investor Relations (650) 218-6900

Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement